The Next Phase: Exploring Innovation in Clinical Trials
Gesamtdauer:
13 h 33 min
How DCT and AI Are Here to Transform Clinical Trials
The Next Phase: Exploring Innovation in Clinical Trials
23:12
Cultivating Collaboration and Connectivity for Industry-Wide Standardization
The Next Phase: Exploring Innovation in Clinical Trials
24:31
Shaping the Future of Clinical Trials: The Pivotal Role of Technology
The Next Phase: Exploring Innovation in Clinical Trials
30:01
Leading Change in the Clinical Trial Industry
The Next Phase: Exploring Innovation in Clinical Trials
35:34
Collaborative Mindset: The Future of the Clinical Industry
The Next Phase: Exploring Innovation in Clinical Trials
20:27
Advancing Site Operations: Enhancing Clinical Trial Processes Through Technology Innovation
The Next Phase: Exploring Innovation in Clinical Trials
28:48
Tech Trends & Transformations: in Clinical Trials: A Conversation with WCG
The Next Phase: Exploring Innovation in Clinical Trials
24:22
GCSA: The Global Quality Standard for Clinical Research Sites
The Next Phase: Exploring Innovation in Clinical Trials
19:41
Enrolling Patients: Trends and Technologies Bringing Research Closer
The Next Phase: Exploring Innovation in Clinical Trials
25:21
Building a Single Source of Truth for Healthcare Data
The Next Phase: Exploring Innovation in Clinical Trials
21:55
Empowering the Next Generation of Researchers: From 'Buts' to Breakthroughs
The Next Phase: Exploring Innovation in Clinical Trials
19:19
Trials by Design: Crafting the Future of Patient-Centric Experiences
The Next Phase: Exploring Innovation in Clinical Trials
24:59
DCTs: Trials and Tribulations
The Next Phase: Exploring Innovation in Clinical Trials
18:57
The Hill to Climb for Scaling Clinical Trials: A POV from an Industry Operator
The Next Phase: Exploring Innovation in Clinical Trials
19:50
The Hard & Soft Skills Needed to Succeed in Clinical Research
The Next Phase: Exploring Innovation in Clinical Trials
24:08
The Future of Clinical Trials: Expanding DEI Initiatives
The Next Phase: Exploring Innovation in Clinical Trials
17:14
Paradigm Shift: How New Tech is Shaping the Future of Clinical Trials
The Next Phase: Exploring Innovation in Clinical Trials
21:53
Disrupting Clinical Trials: The Role of Tech and Innovation
The Next Phase: Exploring Innovation in Clinical Trials
18:35
Improving the Patient and Provider Experience
The Next Phase: Exploring Innovation in Clinical Trials
24:35
The Future of Patient Care and Clinical Research
The Next Phase: Exploring Innovation in Clinical Trials
24:14
Interoperability and Data in Healthcare
The Next Phase: Exploring Innovation in Clinical Trials
28:59
Underrepresentation in Clinical Trials
The Next Phase: Exploring Innovation in Clinical Trials
28:09
A Look Back: Key Learnings in Clinical Research Innovation
The Next Phase: Exploring Innovation in Clinical Trials
23:41
The Evolution of Real-World Evidence in Epidemiology
The Next Phase: Exploring Innovation in Clinical Trials
18:51
Data Powering Actionable Outcomes in Clinical Trials
The Next Phase: Exploring Innovation in Clinical Trials
15:13
Considering the Patient Experience in Decentralized Trials
The Next Phase: Exploring Innovation in Clinical Trials
20:59
Investment Trends in the Clinical Research Industry
The Next Phase: Exploring Innovation in Clinical Trials
26:44
Decentralized Trials in a Post-Pandemic World
The Next Phase: Exploring Innovation in Clinical Trials
29:44
Diversity and Inclusion in Clinical Research
The Next Phase: Exploring Innovation in Clinical Trials
21:40
eTMF: The Future of Real-Time Collaboration
The Next Phase: Exploring Innovation in Clinical Trials
24:59
Technology and Streamlining Clinical Operations
The Next Phase: Exploring Innovation in Clinical Trials
22:41
The Evolving Role of the CRA/CTA
The Next Phase: Exploring Innovation in Clinical Trials
24:00
A Deep Dive into Florence’s 2021 State of the Industry Report
The Next Phase: Exploring Innovation in Clinical Trials
37:58
Improving Collaboration in Molecular Diagnostics
The Next Phase: Exploring Innovation in Clinical Trials
22:16
